CompuGroup Medical SE & Co. KGaA (VIE:COP2)
26.78
+0.16 (0.60%)
At close: Feb 2, 2026
VIE:COP2 Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,201 | 1,186 | 1,228 | 1,175 | 1,063 | 869.13 |
Other Revenue | 0.6 | 0.6 | 0.11 | 0.25 | 0.08 | 0.08 |
| 1,201 | 1,186 | 1,228 | 1,175 | 1,063 | 869.21 | |
Revenue Growth (YoY) | 0.70% | -3.39% | 4.52% | 10.55% | 22.26% | 12.82% |
Cost of Revenue | 798.78 | 784.28 | 813.16 | 763.1 | 689.15 | 533.23 |
Gross Profit | 402.42 | 402.03 | 414.75 | 411.71 | 373.55 | 335.98 |
Selling, General & Admin | 12.01 | 12.01 | 11.85 | 11.63 | 10.78 | 8.82 |
Amortization of Goodwill & Intangibles | 65.78 | 66.81 | 64.51 | 69.21 | 66.72 | 44.85 |
Other Operating Expenses | 192.91 | 172.24 | 164.46 | 179.32 | 144.21 | 126.97 |
Operating Expenses | 325.89 | 304.11 | 292.09 | 313.14 | 266.92 | 215.79 |
Operating Income | 76.53 | 97.92 | 122.66 | 98.56 | 106.63 | 120.19 |
Interest Expense | -30.88 | -31.43 | -24.32 | -9.12 | -5.4 | -5.3 |
Interest & Investment Income | 1.51 | 1.32 | 1.06 | 0.81 | 0.72 | 1.52 |
Earnings From Equity Investments | 0.8 | -0.8 | 0.62 | -0.1 | 0.03 | -0.93 |
Currency Exchange Gain (Loss) | -3.13 | 0.02 | -2.94 | 1.08 | -0.39 | -4.27 |
Other Non Operating Income (Expenses) | -12.51 | -10.18 | -15.18 | 17.27 | 0.74 | -0.92 |
EBT Excluding Unusual Items | 32.32 | 56.85 | 81.9 | 108.51 | 102.34 | 110.29 |
Gain (Loss) on Sale of Assets | 5.85 | 5.85 | 1.04 | 0.16 | 1.69 | 0.14 |
Asset Writedown | -1.87 | -1.87 | -11.45 | -0.34 | -6.15 | - |
Other Unusual Items | -1.54 | -3.53 | 0.64 | -1.51 | 0 | - |
Pretax Income | 39.35 | 61.89 | 72.67 | 106.82 | 97.87 | 110.43 |
Income Tax Expense | 20.44 | 27.13 | 25.8 | 32.7 | 28.84 | 37.01 |
Earnings From Continuing Operations | 18.91 | 34.76 | 46.87 | 74.12 | 69.03 | 73.42 |
Net Income to Company | 18.91 | 34.76 | 46.87 | 74.12 | 69.03 | 73.42 |
Minority Interest in Earnings | -0.66 | -0.16 | -0.96 | -0.71 | -0.06 | -0.23 |
Net Income | 18.25 | 34.6 | 45.92 | 73.41 | 68.97 | 73.19 |
Net Income to Common | 18.25 | 34.6 | 45.92 | 73.41 | 68.97 | 73.19 |
Net Income Growth | -43.84% | -24.64% | -37.45% | 6.44% | -5.77% | 11.20% |
Shares Outstanding (Basic) | 52 | 52 | 52 | 52 | 53 | 51 |
Shares Outstanding (Diluted) | 53 | 53 | 52 | 52 | 53 | 52 |
Shares Change (YoY) | 1.10% | 0.63% | 0.32% | -1.29% | 1.15% | 5.96% |
EPS (Basic) | 0.35 | 0.67 | 0.88 | 1.41 | 1.30 | 1.43 |
EPS (Diluted) | 0.35 | 0.66 | 0.88 | 1.40 | 1.30 | 1.40 |
EPS Growth | -42.89% | -24.92% | -37.21% | 7.69% | -7.14% | 5.26% |
Free Cash Flow | 142.8 | 104.08 | 160.56 | 119.18 | 138.23 | 132.25 |
Free Cash Flow Per Share | 2.70 | 1.97 | 3.06 | 2.28 | 2.61 | 2.52 |
Dividend Per Share | 0.050 | 0.050 | 1.000 | 0.500 | 0.500 | 0.500 |
Dividend Growth | -95.00% | -95.00% | 100.00% | - | - | - |
Gross Margin | 33.50% | 33.89% | 33.78% | 35.05% | 35.15% | 38.65% |
Operating Margin | 6.37% | 8.25% | 9.99% | 8.39% | 10.03% | 13.83% |
Profit Margin | 1.52% | 2.92% | 3.74% | 6.25% | 6.49% | 8.42% |
Free Cash Flow Margin | 11.89% | 8.77% | 13.08% | 10.14% | 13.01% | 15.21% |
EBITDA | 124.51 | 146.86 | 169.81 | 151.77 | 160.91 | 158.65 |
EBITDA Margin | 10.37% | 12.38% | 13.83% | 12.92% | 15.14% | 18.25% |
D&A For EBITDA | 47.98 | 48.94 | 47.15 | 53.2 | 54.28 | 38.46 |
EBIT | 76.53 | 97.92 | 122.66 | 98.56 | 106.63 | 120.19 |
EBIT Margin | 6.37% | 8.25% | 9.99% | 8.39% | 10.03% | 13.83% |
Effective Tax Rate | 51.95% | 43.84% | 35.50% | 30.61% | 29.47% | 33.51% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.